8月28日（周三）晚上六点半至九点，上海健谈会、华平投资、毕马威、上海美国商会将共同举办一场研讨会，主题为"迎接中国医疗器械行业的挑战"。此次活动的主办方中国医药城将简单地介绍CMC(中国医药城)。

On Wednesday, August 28th from 6:00 p.m. to 9:00 p.m., Shanghai Healthcare Drinks, Warburg Pincus, KPMG, and AmCham Shanghai and will hold an after work discussion panel entitled "Overcoming Challenges in the China Medical Device Industry". This event is sponsored by China Medical City who will give a brief presentation on CMC.

本次研讨会由HTDK（华瑭大昌）执行董事金路主持，研讨小组嘉宾包括：

* 许立 - 豪洛捷医疗副总裁兼中国区总经理

* 崔腾 – 莱诺医疗首席执行官

* 凌春华 – 伟亚安医疗中国区总经理

* 李永明 – 捷迈医疗大中华总经理

* 赵瑞麟 – 辰德资本合伙人（前宜曼达（Illumina）大中华区总经理）

The panel will be moderated by William Jin, Executive Director of HTDK, and consists of the following executives:

* Ruilin Zhao - Partner, CD Capital (former Greater China GM of Illumina)

* Li Xu - Vice President and General Manager of Hologic China

* Terry Cui – CEO, Nanos Medical

* Edward Ling – Country Manager, Vyaire Medical

* Yongming Li, Greater China General Manager, Zimmer

研讨会开始前，毕马威全球战略集团副总监许宗迪将带来二十分钟的演讲，主题为："医疗器械2030展望以及新政策下的启示 "。

Prior to the panel, Jessica Xu, Associate Director of the KPMG Global Strategy Group, will set the stage with a twenty minute presentation on "Medical Device 2030 and New Medical Device Regulatory Policy Implications."

圆桌研讨会将围绕两票制、不断变化的监管环境、政府的成本控制、当前贸易摩擦下如何规范当前医疗器械市场以及提高技术推动行业未来的问题展开讨论.

The panel discussion will cover how to navigate the current medical device market in regards to the two-invoice system, the constantly changing regulatory environment, cost containment efforts by the government, the current trade frictions and advances in technologies driving the future of the industry.

--------------------------------------------------------------

会议议程 - Agenda

6:00-6:30 入场签到 - Registration

6:30-6:40 开幕式 - Opening

6:40-7:00 毕马威医疗器械2030演讲 - KPMG Medical Device 2030 Presentation

7:00-7:20 CMC演讲 - CMC Presentation

7:20-8:15 圆桌讨论 - Panel Discussion

8:15-8:30 现场问答 - Q&A

8:30-9:00 联谊交流 - Networking